Raymond James & Associates’s Westlake Chemical Partners WLKP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $424K | Sell |
18,900
-25,323
| -57% | -$575K | ﹤0.01% | 3201 |
|
|
2024
Q2 | $999K | Sell |
44,223
-4,763
| -10% | -$106K | ﹤0.01% | 2622 |
|
|
2024
Q1 | $1.09M | Buy |
48,986
+28,943
| +144% | +$650K | ﹤0.01% | 2542 |
|
|
2023
Q4 | $434K | Buy |
20,043
+6,043
| +43% | +$132K | ﹤0.01% | 3037 |
|
|
2023
Q3 | $305K | Sell |
14,000
-6,059
| -30% | -$135K | ﹤0.01% | 3213 |
|
|
2023
Q2 | $435K | Sell |
20,059
-18,076
| -47% | -$396K | ﹤0.01% | 3022 |
|
|
2023
Q1 | $839K | Buy |
38,135
+18,424
| +93% | +$432K | ﹤0.01% | 2565 |
|
|
2022
Q4 | $463K | Buy |
19,711
+5,611
| +40% | +$127K | ﹤0.01% | 2955 |
|
|
2022
Q3 | $303K | Sell |
14,100
-32,212
| -70% | -$778K | ﹤0.01% | 3178 |
|
|
2022
Q2 | $1.15M | Buy |
46,312
+7,877
| +20% | +$211K | ﹤0.01% | 2347 |
|
|
2022
Q1 | $1.04M | Buy |
38,435
+26,389
| +219% | +$701K | ﹤0.01% | 2568 |
|
|
2021
Q4 | $324K | Buy |
+12,046
| New | +$299K | ﹤0.01% | 3386 |
|
|
2021
Q2 | – | Sell |
-15,943
| Closed | -$383K | – | 4227 |
|
|
2021
Q1 | $383K | Sell |
15,943
-2,827
| -15% | -$66.5K | ﹤0.01% | 3200 |
|
|
2020
Q4 | $447K | Sell |
18,770
-66
| -0.4% | -$1.34K | ﹤0.01% | 2888 |
|
|
2020
Q3 | $353K | Buy |
18,836
+911
| +5% | +$18.1K | ﹤0.01% | 2849 |
|
|
2020
Q2 | $339K | Buy |
17,925
+3,220
| +22% | +$58.6K | ﹤0.01% | 2852 |
|
|
2020
Q1 | $217K | Sell |
14,705
-1,523
| -9% | -$31.9K | ﹤0.01% | 2983 |
|
|
2019
Q4 | $429K | Buy |
16,228
+6,644
| +69% | +$153K | ﹤0.01% | 2838 |
|
|
2019
Q3 | $223K | Buy |
9,584
+222
| +2% | +$5.03K | ﹤0.01% | 3193 |
|
|
2019
Q2 | $230K | Buy |
9,362
+272
| +3% | +$6.28K | ﹤0.01% | 3164 |
|
|
2019
Q1 | $206K | Buy |
9,090
+392
| +5% | +$8.93K | ﹤0.01% | 3225 |
|
|
2018
Q4 | $210K | Sell |
8,698
-901
| -9% | -$20.8K | ﹤0.01% | 3102 |
|
|
2018
Q3 | $239K | Sell |
9,599
-7,077
| -42% | -$180K | ﹤0.01% | 3184 |
|
|
2018
Q2 | $409K | Sell |
16,676
-7
| -0% | -$163 | ﹤0.01% | 2820 |
|
|
2018
Q1 | $373K | Buy |
16,683
+770
| +5% | +$18.1K | ﹤0.01% | 2751 |
|
|
2017
Q4 | $397K | Buy |
15,913
+352
| +2% | +$7.96K | ﹤0.01% | 2672 |
|
|
2017
Q3 | $353K | Buy |
15,561
+331
| +2% | +$7.97K | ﹤0.01% | 2686 |
|
|
2017
Q2 | $377K | Buy |
15,230
+522
| +4% | +$12.9K | ﹤0.01% | 2583 |
|
|
2017
Q1 | $370K | Sell |
14,708
-881
| -6% | -$21.3K | ﹤0.01% | 2565 |
|
|
2016
Q4 | $337K | Sell |
15,589
-2,377
| -13% | -$51K | ﹤0.01% | 2564 |
|
|
2016
Q3 | $410K | Sell |
17,966
-1,369
| -7% | -$31.1K | ﹤0.01% | 2408 |
|
|
2016
Q2 | $386K | Sell |
19,335
-1,576
| -8% | -$31.6K | ﹤0.01% | 2249 |
|
|
2016
Q1 | $412K | Sell |
20,911
-1,212
| -5% | -$22.5K | ﹤0.01% | 2146 |
|
|
2015
Q4 | $491K | Sell |
22,123
-550
| -2% | -$9.95K | ﹤0.01% | 1997 |
|
|
2015
Q3 | $397K | Sell |
22,673
-6,277
| -22% | -$129K | ﹤0.01% | 2022 |
|
|
2015
Q2 | $630K | Buy |
28,950
+4,600
| +19% | +$110K | ﹤0.01% | 1976 |
|
|
2015
Q1 | $653K | Buy |
24,350
+14,100
| +138% | +$371K | ﹤0.01% | 1904 |
|
|
2014
Q4 | $297K | Buy |
+10,250
| New | +$293K | ﹤0.01% | 2137 |
|
Other funds holding WLKP
EIP
TCA
Raymond James & Associates's WLKP Position: Q3 2024 in Review
Raymond James & Associates reduced its Westlake Chemical Partners (WLKP) stake by 57% in Q3 2024, selling an estimated $575K and leaving 18,900 shares worth $424K. The position accounts for ﹤0.01% of the portfolio, ranked #3201.
Raymond James & Associates first reported a position in WLKP in Q4 2014 and has held it in 38 quarters since. The position peaked at $1.15M in Q2 2022. 56 funds tracked by Wall St. Rank hold WLKP as of Q3 2024.
- Raymond James & Associates held 18,900 shares of Westlake Chemical Partners worth $424K as of Q3 2024.
- Raymond James & Associates sold 25,323 Westlake Chemical Partners shares in Q3 2024, an estimated $575K.
- Westlake Chemical Partners made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3201 holding.
- Raymond James & Associates first reported a position in Westlake Chemical Partners in Q4 2014 and has held it in 38 quarters since.
- Raymond James & Associates's Westlake Chemical Partners position peaked at $1.15M in Q2 2022.
- 56 funds tracked by Wall St. Rank held Westlake Chemical Partners as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.